Duration of Type 2 Diabetes Negatively Linked to Mean Cortical Thickness
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 16, 2023 -- Pima American Indians with longer duration of type 2 diabetes (T2D) have decreased cortical thickness and gray matter volumes and increased volume of white matter hyperintensity, according to a study published online July 30 in the Annals of Clinical and Translational Neurology.
Evan L. Reynolds, Ph.D., from the University of Michigan in Ann Arbor, and colleagues conducted a cross-sectional study to examine associations between cognition and magnetic resonance imaging-derived brain outcomes with obesity, diabetes duration, and metabolic risk factors among 51 Pima American Indians with T2D for a mean of 20.1 years.
The researchers found that compared with normative data, study participants had similar cognition (National Institutes of Health Toolbox Cognition Battery composite, 45.3). Associations were seen for T2D duration, but not other metabolic risk factors, with decreased cortical thickness, gray matter volume, and increased white matter hyperintensity volume.
"This study is critical to our understanding of how diabetes affects brain health and lays the groundwork for a larger, longitudinal study addressing how persons with diabetes can maintain a healthy brain," senior author Eva Feldman, M.D., Ph.D., also of the University of Michigan, said in a statement. "Regardless of the underlying mechanisms, preventing these conditions in people with type 2 diabetes is critical to maintaining brain health. Educating the public on the risks that diabetes poses to preserving a healthy brain is part of our mission."
Two authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.